President Donald Trump’s administration recently cancelled billions of dollars in funding to the National Institutes of Health (NIH), causing widespread concern among researchers and tech developers in the healthcare world.
These cuts are currently paused while being challenged in court — but regardless of the litigation’s outcomes, healthcare researchers are girding for an eventual reduction in investment.
Healthcare experts interviewed for this article said NIH funding cuts will disrupt the pace of medical research in the U.S. — which will not only hamper the commercialization of novel treatments but could also hurt the country’s position as a global leader in healthcare and technology advancement.
The consensus seems to be that researchers and startups will need to increase their reliance on private industry and nonprofit funding sources — or else, the U.S. could fall behind other nations when it comes to healthcare innovation. However, some healthcare experts saw a potential for faster grant timelines and improved efficiency as a result of the funding cuts.
Full story: NIH Cuts: A Push for Efficiency or a Blow to US Healthcare Innovation? – MedCity News
